Abstract: Systems and methods for managing on-shelf availability (OSA) and phantom inventory. The method includes determining a classification for one or more products, generating, based on the determined classification, a day-level forecast for the one or more products, generating, based on the generated day-level forecast, an alert associated with the one or more products, the generated alert indicating an on-shelf availability (OSA) issue with the one or more products, and outputting the generated alert.

Abstract: Systems and methos for generating a schematic for shelf space in a retail environment include acquiring fixture data for a fixture; acquiring item data for a plurality of items to be displayed on fixture; importing an existing planogram, the imported existing planogram comprising an existing location of each item of the plurality of items on the fixture; based on identified assortment rules, generating an updated planogram for the fixture, the generated updated planogram for the fixture including an optimized placement of the plurality of items on the fixture; and generating the schematic based on the generated updated planogram, the generated recommended schematic including a sequence of the plurality of items included in the generated updated planogram.

Abstract: The invention relates to utilizing a magnetoresistance as part of a computing element in a computing device. In particular, the invention relates to neural networks and neuromorphic computing devices that implement magnetoresistance to adjust certain parameters of the neural network/neuromorphic computing devices. Such a computing device can comprise electronic circuitry comprising source circuitry and read-out circuitry, one or more magnetoresistive elements, and a control element, configured to magnetize each of the one or more magnetoresistive element to adjust the resistance of each magnetoresistive element between at least three resistance values. Such a computing device can be used to operate an artificial neural network.

Abstract: There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.

Abstract: There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.

Abstract: There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.

Abstract: A tool and method for automating the process of forecasting are disclosed. The tool includes a data collector for collecting data from a plurality of sources. An extractor extracts, from the collected data, the predictor data streams and elements to be used for forecasting. The predictor data streams and elements are analyzed for completeness and their corresponding characteristics are determined. Further, the predictor data streams and elements are arranged into multiple sets such that each set has a common data pattern. A plurality of forecasting models and the corresponding unique properties and a unique master list of their forecasting parameters, are stored in a second repository. The unique properties are compared with the properties of each of the forecasting models, and a set of forecasting models suitable for performing a forecast are identified and ranked. The most appropriate forecasting model is selected and provided to the forecasting engine, for forecasting.

Abstract: A method for operating an electronic display device and the electronic display device are provided. The method may include configuring a plurality of modules of the electronic display device into a stand-by mode, receiving an input corresponding to a feature selected from among a plurality of features of the electronic display device, and initializing, from among the plurality of modules, one or more modules that correspond to the feature selected of the electronic display device, wherein one or more of the plurality of modules respectively correspond to one or more of the plurality of features.

Abstract: There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, pre-diabetic or have diabetes, obesity and/or syndrome X. Hence the compounds of the present invention help to manage blood sugar levels, i.e. helping the body by balancing the blood sugar levels; helping to keep balanced blood glucose levels, particularly in humans with diabetes; aiding by enhancing the glucose uptake by the cells and by reducing sugar levels, thus improving or restoring the glucose tolerance; optimizing the glycemic response; normalizing the glucose tolerance.

Abstract: The invention provides a technique for integrating a plurality of media streams, including a main program and a stream of customized information at a terminal so that a user gets a single playback. Prior to streaming a main program to a user, the main program is embedded with placeholders. These placeholders include a definition of a location for insertion of customized media content and a pointer to another server. As the user receives the main program and embedded placeholders, these pointers get directed from the user's terminal to streaming server, which responds by identifying appropriate media and streaming the media to the user's terminal. Software on the user's terminal (also known as a “player”) integrates the various data streams and synchronizes them to a main program. The user's terminal may receive many media streams from different streaming servers and integrate each stream into a single playback.